mhurhangee/ep-ind-claims huggingface dataset:
An apparatus configured to be employed in a User Equipment, UE, (502 1) comprising: one or more processors configured to: generate a Direct Communication Request for a connection to a peer UE (502 2), wherein the Direct Communication Request indicates security capabilities of the UE and a signaling security policy of the UE; receive a Direct Security Mode Reject message from the peer UE, when the peer UE rejects the Direct Communication Request based on a comparison of a security policy of the peer UE with the signaling security policy of the UE or with the security capabilities of the UE; process a Direct Security Mode Command from the peer UE, wherein the Direct Security Mode Command indicates the security capabilities of the UE, the signaling security policy of the UE and a set of chosen algorithms for data protection; determine whether to accept the connection, based at least on the signaling security policy of the UE; and in response to a determination to accept the connection, generate a Direct Security Mode Complete message for the peer UE based at least on the set of chosen algorithms. generate a Direct Communication Request for a connection to a peer UE (502 2), wherein the Direct Communication Request indicates security capabilities of the UE and a signaling security policy of the UE; receive a Direct Security Mode Reject message from the peer UE, when the peer UE rejects the Direct Communication Request based on a comparison of a security policy of the peer UE with the signaling security policy of the UE or with the security capabilities of the UE; process a Direct Security Mode Command from the peer UE, wherein the Direct Security Mode Command indicates the security capabilities of the UE, the signaling security policy of the UE and a set of chosen algorithms for data protection; determine whether to accept the connection, based at least on the signaling security policy of the UE; and in response to a determination to accept the connection, generate a Direct Security Mode Complete message for the peer UE based at least on the set of chosen algorithms.
Neramexane or a pharmaceutically acceptable salt thereof for use in the treatment or the prevention of tinnitus associated with hearing loss or mild hearing loss.
A method comprising: - displaying a keyboard on a touch-sensitive display of an electronic device; - detecting a tilt of the electronic device, wherein the electronic device comprises an orientation sensor that is configured to detect tilts of the electronic device; and - resizing one or more keys of the keyboard in response to detecting the tilt being associated with a keyboard transformation function, wherein the detected tilt is associated with the keyboard transformation function when the detected tilt comprises a sideward tilt; wherein the resizing comprises changing the width of the keys, wherein one or more keys proximate a first tilted up side of the electronic device are resized to be larger than one or more keys proximate a second tilted down side of the electronic device, the keys gradually decreasing in width from the first, tilted up side to the second, tilted down side; and wherein the resizing further comprises enlarging the width of the one or more keys proximate the first tilted up side of the device further by reducing the number of keys displayed by simulating a sliding movement such that a portion of the keyboard appears to slide out of view. - displaying a keyboard on a touch-sensitive display of an electronic device; - detecting a tilt of the electronic device, wherein the electronic device comprises an orientation sensor that is configured to detect tilts of the electronic device; and - resizing one or more keys of the keyboard in response to detecting the tilt being associated with a keyboard transformation function, wherein the detected tilt is associated with the keyboard transformation function when the detected tilt comprises a sideward tilt;
An antibody or an antigen binding fragment thereof that specifically binds to and neutralizes TOPEβ1, TGFβ2 and TGFβ3 for use in a method for treating osteogenesis imperfecta in a human subject in need thereof in combination with a bisphosphonate, wherein the antibody comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 10, and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 11.
A radiographic image processing method comprising: a step of acquiring a radiographic image of a phantom using a system that radiates radiation to a target object and captures an image of the radiation passing through the target object to acquire a radiographic image; a step of specifying image characteristics of the radiographic image of the phantom; a step of selecting a trained model on the basis of the image characteristics from a plurality of trained models constructed through machine learning in advance using image data; a step of acquiring a radiographic image of the target object using the system; and a step of executing image processing for removing noise from the radiographic image of the target object using the selected trained model. a step of acquiring a radiographic image of a phantom using a system that radiates radiation to a target object and captures an image of the radiation passing through the target object to acquire a radiographic image; a step of specifying image characteristics of the radiographic image of the phantom; a step of selecting a trained model on the basis of the image characteristics from a plurality of trained models constructed through machine learning in advance using image data; a step of acquiring a radiographic image of the target object using the system; and a step of executing image processing for removing noise from the radiographic image of the target object using the selected trained model.
A method comprising: receiving generator data for operation of a generator; receiving engine data for operation of an engine coupled to the generator; calculating an estimated oil life based at least on the generator data or the engine data (31, 33); characterized by calculating a load factor based on the generator load; and multiplying the estimated oil life by the load factor to calculate an updated oil life. receiving generator data for operation of a generator; receiving engine data for operation of an engine coupled to the generator; calculating an estimated oil life based at least on the generator data or the engine data (31, 33); characterized by calculating a load factor based on the generator load; and multiplying the estimated oil life by the load factor to calculate an updated oil life.
An article comprising: a substrate having a first major surface, wherein the major surface has an emissivity not greater than 0.2; and an exposed hardcoat on the first major surface, the exposed hardcoat comprising binder, wherein the binder comprises surfactant, and, wherein the exposed hardcoat has a thickness less than 200 nanometers and has a scratch rating of not greater than 1 as determined by the Linear Abrasion Test in the Examples. a substrate having a first major surface, wherein the major surface has an emissivity not greater than 0.2; and an exposed hardcoat on the first major surface, the exposed hardcoat comprising binder, wherein the binder comprises surfactant, and,
Refrigeration appliance with at least one first and one second temperature zone (1, 2), a refrigerant circuit, which comprises a compressor, a first evaporator for cooling the first temperature zone and a second evaporator for cooling the second temperature zone, wherein the first evaporator is serially connected downstream of the second evaporator in the refrigerant circuit and a first controllable throttle point in the refrigerant circuit is connected upstream of the first evaporator and downstream of the second evaporator, wherein a compressor regulator is designed to control the rotational speed of the compressor on the basis of the temperature of the first temperature zone, characterised in that at least one third evaporator to regulate the temperature of a third temperature zone is connected upstream of the second evaporator in the refrigerant circuit via a second controllable throttle point and that a second throttle regulator is provided to control the degree of opening of the second controllable throttle point on the basis of the temperature of the third temperature zone.
An airfoil (400; 530) for a gas turbine engine, the airfoil comprising: an airfoil body (402; 532) extending between a leading edge (412; 538) and a trailing edge in an axial direction, between a pressure side and a suction side in a circumferential direction, and between a root and a tip in a radial direction; a first transitioning leading edge cavity (422; 534) located proximate the leading edge proximate the root of the airfoil body and transitioning axially toward the trailing edge as the first transitioning leading edge cavity extends radially toward the tip; and a second transitioning leading edge cavity (424; 536) located aft of the first transitioning leading edge cavity proximate the root of the airfoil body and transitioning axially toward the leading edge as the second transitioning leading edge cavity extends radially toward the tip; characterized in that: the second transitioning leading edge cavity comprises an impingement sub-cavity (424a; 536a) and a film sub-cavity (424b; 536b) along the leading edge and proximate the tip, and the first transitioning leading edge cavity comprises a pressure side sub-cavity (422a; 534a) proximate the tip and a suction side sub-cavity (422b; 534b) proximate the tip. an airfoil body (402; 532) extending between a leading edge (412; 538) and a trailing edge in an axial direction, between a pressure side and a suction side in a circumferential direction, and between a root and a tip in a radial direction; a first transitioning leading edge cavity (422; 534) located proximate the leading edge proximate the root of the airfoil body and transitioning axially toward the trailing edge as the first transitioning leading edge cavity extends radially toward the tip; and a second transitioning leading edge cavity (424; 536) located aft of the first transitioning leading edge cavity proximate the root of the airfoil body and transitioning axially toward the leading edge as the second transitioning leading edge cavity extends radially toward the tip; characterized in that: the second transitioning leading edge cavity comprises an impingement sub-cavity (424a; 536a) and a film sub-cavity (424b; 536b) along the leading edge and proximate the tip, and the first transitioning leading edge cavity comprises a pressure side sub-cavity (422a; 534a) proximate the tip and a suction side sub-cavity (422b; 534b) proximate the tip. the second transitioning leading edge cavity comprises an impingement sub-cavity (424a; 536a) and a film sub-cavity (424b; 536b) along the leading edge and proximate the tip, and the first transitioning leading edge cavity comprises a pressure side sub-cavity (422a; 534a) proximate the tip and a suction side sub-cavity (422b; 534b) proximate the tip.
Pressure profiling device, particularly for dispensing units of pressurized liquids, comprising a pump adapted to generate a flow of a pressurized liquid in outlet, said pump being configured to be connected, by means of at least one delivery duct (5, 5'), to at least one dispensing unit (7, 7') of said liquid, a three-way hydraulic fitting (9, 9') being applied to said at least one delivery duct (5, 5'), said three-way hydraulic fitting (9, 9') being configured to divert a first part of said liquid leaving said pump into a bypass duct (11, 11'), a remaining second part of said liquid continuing on said at least one delivery duct (5, 5'), a proportional valve (13, 13') being applied to said bypass duct (11, 11'), wherein said proportional valve (13, 13') can be operated to vary the flow rate of said first part of said liquid diverted in said bypass duct (11, 11') as a function of the degree of opening of said proportional valve (13, 13') so as to vary the pressure of the remaining second part of said liquid, characterized in that a restriction (15, 15') is applied to said at least one delivery duct (5, 5') between said pump and said three-way hydraulic fitting (9, 9'), said restriction (15, 15') being configured to impose a reduction in the flow rate of said liquid leaving said pump.
Thermal and acoustical Insulation (1, 10, 20, 30) with a temperature-resistant and sound-absorbing corpus and with a heat-resistant, sound-absorbing, porous material layer (4, 4a) of metal wire mesh, arranged at that side of the corpus facing the sound source after having been installed, characterized in that the metal wire mesh is of chrome nickel stainless steel and has a porosity between 10 % to 60 %.
A method of etherification, the method comprising: reducing templates of a zeolite catalyst to provide a reduced template zeolite catalyst having from 3 to 15 weight percent of templates maintained following calcination of the zeolite catalyst; and contacting the reduced template zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether; wherein the zeolite catalyst is a zeolite beta catalyst, and wherein the alcohol is a (poly)alkylene glycol. reducing templates of a zeolite catalyst to provide a reduced template zeolite catalyst having from 3 to 15 weight percent of templates maintained following calcination of the zeolite catalyst; and contacting the reduced template zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether;
An arrangement comprising an electrical device which has a device housing and at least one female socket with an insertion opening, and a connecting cable by means of which the electrical device can be connected to a further electrical apparatus and which is connected to the device by a cable plug attached to the connecting cable, which plug has a plug housing and an insertion extension projecting out of the plug housing with which the cable plug is inserted into the female socket of the electrical device and which has electrical contact elements which contact electrical counter-contact elements of the female socket, wherein the device housing is formed with a shaft which starts from an outer surface of the device housing, the longitudinal extent of which shaft runs in rectilinear manner in the direction of a longitudinal axis, and the connection of the connecting cable to the electrical device takes place by inserting the cable plug into the shaft, wherein the cable plug can be inserted with its plug extension into the insertion opening of the female socket and the direction of insertion of the plug extension of the cable plug into the female socket is parallel to the longitudinal axis of the shaft and the plug housing of the cable plug which is inserted with its insertion extension into the female socket at least over a portion of its length lies within the shaft of the device housing, characterised in that the plug housing over at least half its length measured parallel to the longitudinal axis of the shaft lies in the shaft and in that the plug housing in the shaft, with respect to a freedom of movement in a direction at right-angles to the longitudinal axis of the shaft, has a play which is less than 0.5 mm, or is without play, and in that the plug housing in the shaft, with respect to tilting about an axis at right-angles to the longitudinal axis of the shaft, has a play which is less than 2°, or is without play.
An absorbent article comprising: an absorbent body composed of at least one absorption layer, wherein the absorbent body includes a hydrophobized adsorbent obtained by a hydrophobizsation treatment on a skin surface side thereof and a water absorbent resin powder having an absorption speed in a range from 6 seconds to 60 seconds determined by a vortex method, wherein the water absorbent resin powder is a crosslinked polymer mainly composed of acrylic acid and having carboxyl groups thereof being at least partially neutralized. an absorbent body composed of at least one absorption layer, wherein the absorbent body includes a hydrophobized adsorbent obtained by a hydrophobizsation treatment on a skin surface side thereof and a water absorbent resin powder having an absorption speed in a range from 6 seconds to 60 seconds determined by a vortex method, wherein the water absorbent resin powder is a crosslinked polymer mainly composed of acrylic acid and having carboxyl groups thereof being at least partially neutralized.
A sexual dysfunction treatment apparatus for treating a female patient, comprising: - an adjustable restriction device comprising at least one restriction member comprising an expandable cavity configured to receive a hydraulic fluid, wherein the restriction member is configured to restrict the venous blood flow leaving the patient's female erectile tissue to thereby increase the amount of blood in the female erectile tissue and obtaining engorgement with blood of the female erectile tissue, - at least one implantable reservoir (1013, 1046) containing hydraulic fluid, - an implantable battery (1022, 1042), - an implantable energy consuming operation device configured to expand the expandable cavity by distributing hydraulic fluid from the at least one reservoir to the cavity to increase the volume of the cavity to restrict the female erectile tissue and to contract the expandable cavity by distributing hydraulic fluid from the cavity to the at least one reservoir to decrease the volume of the cavity to release the restriction of the female erectile tissue, - a control device for controlling the restriction device from outside the patient's body, and said treatment apparatus being characterized in that it further comprises - a measuring unit (1023, 1025) configured to measure at least one of energy consumption voltage of the battery and battery temperature on a regular basis to determine the current state of the battery. - an adjustable restriction device comprising at least one restriction member comprising an expandable cavity configured to receive a hydraulic fluid, wherein the restriction member is configured to restrict the venous blood flow leaving the patient's female erectile tissue to thereby increase the amount of blood in the female erectile tissue and obtaining engorgement with blood of the female erectile tissue, - at least one implantable reservoir (1013, 1046) containing hydraulic fluid, - an implantable battery (1022, 1042), - an implantable energy consuming operation device configured to expand the expandable cavity by distributing hydraulic fluid from the at least one reservoir to the cavity to increase the volume of the cavity to restrict the female erectile tissue and to contract the expandable cavity by distributing hydraulic fluid from the cavity to the at least one reservoir to decrease the volume of the cavity to release the restriction of the female erectile tissue, - a control device for controlling the restriction device from outside the patient's body, and said treatment apparatus being characterized in that it further comprises - a measuring unit (1023, 1025) configured to measure at least one of energy consumption voltage of the battery and battery temperature on a regular basis to determine the current state of the battery.
A molded print head, comprising: an epoxy molded compound, EMC,; a print head die embedded in the EMC; a drive integrated circuit, IC, embedded in the EMC; and an interposer embedded in the EMC, wherein the print head die, the drive IC and the interposer are wire bonded within the EMC. an epoxy molded compound, EMC,; a print head die embedded in the EMC; a drive integrated circuit, IC, embedded in the EMC; and an interposer embedded in the EMC, wherein the print head die, the drive IC and the interposer are wire bonded within the EMC.
A genetically modified mouse characterized by one or more symptoms or signs associated with expression of human APOE4p and mouse Trem2p and relevant to non-familial late-onset Alzheimer's disease, the genome of the mouse comprising: 1) a DNA sequence encoding a human APOE4 protein (APOE4p) operably linked to a promoter; and 2) a DNA sequence encoding a mouse Trem2 protein having a mutation p.R47H (Trem2p) operably linked to a promoter, wherein the mouse expresses human APOE4p and mouse Trem2p, wherein the one or more symptoms or signs associated with expression of human APOE4p and mouse Trem2p and relevant to non-familial late-onset Alzheimer's disease is cerebrovascular leakage compared to an APOE3-expressing mouse or wild-type control mouse.
Method of obtaining mesenchymal stem cells, comprising the steps of: • Obtaining Platelet Rich-Fibrin by a centrifugation method from blood taken from a venous blood, • Cutting Platelet rich-fibrin tissue into pieces under a laminar flow cabinet, • Transferring the obtained PRF pieces firstly into D-Lysine coated flasks and adding thereto 8-20% by volume of human serum, animal serum or 0.5-2% by volume of penicillin-streptomycin without serum; 0.5-2% by volume of L-glutamine; inorganic salts, such as calcium chloride, potassium chloride, magnesium sulfate, sodium chloride, sodium bicarbonate, sodium phosphate; amino acids, such as L-alanine, L-arginine, L-asparagine-H2O, L-aspartic acid, L-cystine, L-cysteine-HCl-H2O, L-glutamic acid, L-glutamine, glycine, L-histidine, L- isoleucine, L-leucine, L-lysine, L-methionine, L-phenyl alanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine; vitamins, such as L-ascorbic acid, biotin, D-Capantothenate, choline chloride, folic acid, i-inositol, niacinamide, pyridoxal HCl, riboflavin, thiamine HCl, vitamin B12; alpha MEM medium containing all of D-glucose lipoic acid, sodium pyruvate, phenol red substances, • Culturing in an incubator containing 0,3-5% by volume of COz at 37°C, • Removing of stem cells from the surface to which they were adhered by using 0,01-0,5% by volume of Trypsin-EDTA solution and after 3-8 minutes of centrifugation at 200-400g, • Obtaining PRF-derived Mesenchymal stem cells (PRF-Derived MSCs). • Obtaining Platelet Rich-Fibrin by a centrifugation method from blood taken from a venous blood, • Cutting Platelet rich-fibrin tissue into pieces under a laminar flow cabinet, • Transferring the obtained PRF pieces firstly into D-Lysine coated flasks and adding thereto 8-20% by volume of human serum, animal serum or 0.5-2% by volume of penicillin-streptomycin without serum; 0.5-2% by volume of L-glutamine; inorganic salts, such as calcium chloride, potassium chloride, magnesium sulfate, sodium chloride, sodium bicarbonate, sodium phosphate; amino acids, such as L-alanine, L-arginine, L-asparagine-H2O, L-aspartic acid, L-cystine, L-cysteine-HCl-H2O, L-glutamic acid, L-glutamine, glycine, L-histidine, L- isoleucine, L-leucine, L-lysine, L-methionine, L-phenyl alanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine; vitamins, such as L-ascorbic acid, biotin, D-Capantothenate, choline chloride, folic acid, i-inositol, niacinamide, pyridoxal HCl, riboflavin, thiamine HCl, vitamin B12; alpha MEM medium containing all of D-glucose lipoic acid, sodium pyruvate, phenol red substances, • Culturing in an incubator containing 0,3-5% by volume of COz at 37°C, • Removing of stem cells from the surface to which they were adhered by using 0,01-0,5% by volume of Trypsin-EDTA solution and after 3-8 minutes of centrifugation at 200-400g, • Obtaining PRF-derived Mesenchymal stem cells (PRF-Derived MSCs).